Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic proxies for calcium channel blockers and cancer: a Mendelian randomization study.

Journal of human hypertension - 1 Nov 2023

Fan Bohan, Schooling C Mary, Zhao Jie V

Abstract excerpt

Calcium channel blockers (CCBs) are commonly prescribed antihypertensives. However, concerns exist about potential off-target effects on cancer. This Mendelian randomization (MR) study examined the associations of genetic proxies for CCBs with the risk of cancer. We used published genetic proxies in the target genes of CCBs as instruments, and obtained MR estimates by applying them to large studies of 17...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Polymorphism, Single Nucleotide
Share to Breast Neoplasms
Share to Calcium Channel Blockers

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genome-Wide Association Study

Share to Lung Neoplasms

Share to Mendelian Randomization Analysis

Share to Ovarian Neoplasms

Share to Prostatic Neoplasms

Source

Identifiers

PMID: 37117874
DOI: 10.1038/s41371-023-00835-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic proxies for calcium channel blockers and cancer: a Mendelian randomization study.PMID 37117874Read ↗

Genetically proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancers: A mendelian randomization analysis.Semantic proximity Read ↗

Genetically-proxied therapeutic inhibition of antihypertensive drug targets and risk of common cancersSemantic proximity Read ↗

Using Mendelian randomization study to assess the renal effects of antihypertensive drugsSemantic proximity Read ↗

Antihypertensive drug targets and breast cancer risk: a two-sample Mendelian randomization study.Semantic proximity Read ↗

Evaluating the Impact of Putative Metformin Targets on Cancer Outcomes: A Drug-Target Mendelian Randomization Study.Semantic proximity Read ↗

The evolution of mendelian randomization for investigating drug effects.Semantic proximity Read ↗

Using genetics to assess the association of commonly used antihypertensive drugs with diabetes, glycaemic traits and lipids: a trans-ancestry Mendelian randomisation studySemantic proximity Read ↗

Blood pressure, calcium channel blockers, and the risk of prostate cancer: a Mendelian randomization study.Semantic proximity Read ↗

Association between antihypertensive drugs and hepatocellular carcinoma: A trans-ancestry and drug-target Mendelian randomization study.Semantic proximity Read ↗

Use of Genetic Variants Related to Antihypertensive Drugs to Inform on Efficacy and Side EffectsSemantic proximity Read ↗

Calcium Channel Blockers: clinical outcome associations with reported pharmacogenetics variants in 32,000 patientsSemantic proximity Read ↗

Genetic proxies for antihypertensive drugs and mental disorders: Mendelian randomization study in European and East Asian populationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.